Adaptive Biotechnologies (ADPT) Restructuring Costs (2024 - 2026)
Adaptive Biotechnologies' (ADPT) quarterly Restructuring Costs came in at $643000.0 in Q1 2026, up 639.08% quarter-over-quarter from $87000.0 in Q4 2024.
Adaptive Biotechnologies (ADPT) Restructuring Costs (2024 - 2026) Analysis & Trends
Adaptive Biotechnologies has disclosed Restructuring Costs across 2 years of filings, most recently posting $643000.0 for Q1 2026.
- Restructuring Costs for Q1 2026 came in at $643000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $923000.0 (down 3.85% YoY), and the FY2024 annual result was $2.0 million, changed N/A from the prior year.
- Restructuring Costs came in at $643000.0 for Q1 2026 at Adaptive Biotechnologies, up from $87000.0 in the prior quarter.
- In the past five years, Restructuring Costs ranged from a high of $1.0 million in Q1 2024 to a low of $87000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn |
| 10 | Adaptive Biotechnologies | 2.60 Bn | 2.39 Bn | 52.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 643,000.00 |
| Dec 31, 2024 | 87,000.00 |
| Sep 30, 2024 | 193,000.00 |
| Jun 30, 2024 | 680,000.00 |
| Mar 31, 2024 | 1.04 Mn |